Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
AAM Calls Out Threat Of Consolidation Among Purchasers
Letter To Authorities Accuses Buying Groups And PBMs Of Anticompetitive Activities
Mar 24 2022
•
By
Chloe Kent
AAM has accused drug buying groups of creating a monopsony on generics • Source: Alamy
More from Regulation
More from Policy & Regulation